CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 


Vir Biotechnology Inc 's Net Profit Margin by quarter

Trends, Rankings, Statistics



VIR Net Profit Margin (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Revenue Change 261.49 % - 62271.41 % 46771.68 % 5274.27 %
Seq. Revenue Change - - 51.64 % 684.39 % -41.48 %
Revenue In Millions $374.56 $-40.63 $1,232.46 $812.76 $103.62
Net Profit Margin 46.81 % - 42.08 % 64.63 % -
Net Profit Margin Total Ranking # 273 # # 328 # 248 # 125
Net Income In Millions $175.31 $-76.49 $518.62 $525.25 $110.43
Y / Y Net Income Change 58.76 % - - - -
Seq. Net Income Change - - -1.26 % 375.65 % -


Commenting Third Quarter 2022 Net Profit Margin
Vir Biotechnology Inc has managed to improve its Revenue sequentially to $375 millions by -1021.9 % faster than Net Income increase of -329.19 % to $175 millions, this led to contraction in Net Profit Margin to 46.81 %, below company average.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Net Profit Margin. While Net Profit Margin overall ranking has deteriorated compare to previous quarter from to 273.
Net Margin Formula
VIR's Net Profit Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 6
Healthcare Sector # 29
Overall # 273

Net Profit Margin Statistics
High Average Low
106.57 % 59 % 34.91 %
(Sep 30 2021)   (Jun 30 2021)




Other Net Profit Margin Profitability Ratios
VIR's Cumulative Net Profit Margin
Biotechnology & Pharmaceuticals Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
VIR's Net Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for VIR's Competitors
Net Profit Margin Profit Margin for Vir Biotechnology Inc 's Suppliers
Net Profit Margin Profit Margin for VIR's Customers

You may also want to know
VIR's Annual Growth Rates VIR's Profitability Ratios VIR's Asset Turnover Ratio VIR's Dividend Growth
VIR's Roe VIR's Valuation Ratios VIR's Financial Strength Ratios VIR's Net Income Growth
VIR's Roa VIR's Inventory Turnover Ratio VIR's Growth Rates VIR's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Net Profit MarginSep 30 2022 MRQ Net IncomeSep 30 2022 MRQ Revenue
Poseida Therapeutics Inc   60.54 %$ 70.409 $ 116.306 
Vir Biotechnology Inc   46.81 %$ 175.312 $ 374.557 
Biogen Inc   45.24 %$ 1,134.900 $ 2,508.500 
Voyager Therapeutics Inc   42.90 %$ 17.624 $ 41.086 
Exelixis Inc   40.14 %$ 165.252 $ 411.738 
Quest Patent Research Corp  37.70 %$ 0.104 $ 0.275 
Bio techne Corp  33.28 %$ 89.734 $ 269.655 
Moderna Inc   31.00 %$ 1,043.000 $ 3,364.000 
Halozyme Therapeutics Inc   29.49 %$ 61.634 $ 208.976 
Edwards Lifesciences Corporation  26.04 %$ 343.500 $ 1,319.000 
Lantheus Holdings Inc   25.59 %$ 61.232 $ 239.292 
Gilead Sciences Inc   25.36 %$ 1,786.000 $ 7,042.000 
Mettler Toledo International Inc  22.38 %$ 220.597 $ 985.846 
Idexx Laboratories Inc  21.50 %$ 180.938 $ 841.661 
Intuitive Surgical Inc   20.85 %$ 324.700 $ 1,557.400 
Repligen Corp  20.13 %$ 40.405 $ 200.741 
Neurocrine Biosciences Inc   17.66 %$ 68.500 $ 387.900 
Bruker Corporation  13.84 %$ 88.400 $ 638.900 
Msa Safety Inc  11.76 %$ 44.906 $ 381.694 
Chase Corporation  11.66 %$ 10.273 $ 88.078 
Zimmer Biomet Holdings Inc   11.63 %$ 194.200 $ 1,669.800 
Pactiv Evergreen Inc   10.94 %$ 176.000 $ 1,609.000 
Acuity Brands Inc  10.39 %$ 115.400 $ 1,110.300 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JACK's Profile

Stock Price

JACK's Financials

Business Description

Fundamentals

Charts & Quotes

JACK's News

Suppliers

JACK's Competitors

Customers & Markets

Economic Indicators

JACK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071